ArticleOncogene2022

Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer.

Chune Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.